ARTL
NASDAQ
US
Artelo Biosciences, Inc. - Common Stock
$7.04
▼ $-0.80
(-10.20%)
Vol 431K
1
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$2.5M
ROE
-226.3%
D/E
0.00
Beta
1.08
52W
$1–$29
Wall Street Consensus
6 analysts · Apr 20260
Strong Buy
0
Buy
3
Hold
1
Sell
2
Strong Sell
0.0%
Buy Rating
Price Chart
Similar Stocks
Earnings
Beat rate: 25.0%
Next Report
May 11, 2026
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | — | — | — |
| Dec 2025 | $-4.80 | $-0.12 | +$4.68 |
| Sep 2025 | $-2.51 | $-11.91 | $-9.40 |
| Jun 2025 | $-12.82 | $-16.83 | $-4.01 |
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — |
| Net Income | — | -$3.8M | -$2.4M | -$3.2M | -$3.1M | -$4.2M |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | — | -226.3% | -226.3% | -226.3% | -226.3% | -226.3% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 0.39 | 0.49 | 0.39 | 0.39 | 0.39 | 0.38 |
Key Ratios
ROA (TTM)
-296.8%
P/B
1.2
EPS (TTM)
$-20.88
CF/Share
$-3.33
52W High
$28.60
52W Low
$1.48
$1.48
52-Week Range
$28.60
Financial Health
Free Cash Flow
-$2.9M
Net Debt
$78K
Cash
$600K
Total Debt
$678K
As of Dec 31, 2025
How does ARTL compare to Pharmaceuticals peers?
Peer group: Micro-cap Pharmaceuticals (All) · 171 companies
ARTL valuation vs Pharmaceuticals peers
P/E ratio
—
▼
0%
below
peers
(22.4)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼
0%
below
peers
(5.0)
vs Peers
vs Industry
Overvalued
P/B ratio
1.2
▼
44%
below
peers
(2.1)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(2.0%)
vs Peers
vs Industry
Low yield
ARTL profitability vs Pharmaceuticals peers
ROE
-226.3%
▼
317%
below
peers
(-54.3%)
vs Peers
vs Industry
Weak
Net margin
—
▼
0%
below
peers
(-47.4%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼
0%
below
peers
(68.3%)
vs Peers
vs Industry
In line
ROA
-296.8%
▼
693%
below
peers
(-37.4%)
vs Peers
vs Industry
Weak
ARTL financial health vs Pharmaceuticals peers
D/E ratio
0.0
▼
100%
below
peers
(1.5)
vs Peers
vs Industry
Low debt
Current ratio
0.4
▼
89%
below
peers
(3.4)
vs Peers
vs Industry
Low liquidity
Beta
1.1
▲
15%
above
peers
(0.9)
vs Peers
vs Industry
Less volatile
ARTL fundamentals radar
ARTL
Peer median
Industry
ARTL profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
ARTL vs peers: key metrics
Top Holders
Top 5: 4.54%UBS Group AG
1.58%
$118K
Two Sigma Investments, LP
0.97%
$73K
Virtu Financial LLC
0.79%
$59K
Vanguard Group Inc
0.66%
$49K
Geode Capital Management, L…
0.54%
$40K
As of Dec 31, 2025
Latest News
Cathie Wood Just Made a Startling AI Move. Should You Follow?
Nasdaq · Apr 01
Heartland Opportunistic Value Equity Strategy’s AI Concerns Proved Wrong as Alphabet (GOOGL) …
Yahoo Finance · Mar 25
Heartland Opportunistic Value Equity Strategy’s Investment Journey with Old Republic International (ORI)
Yahoo Finance · Mar 25
Ex-Div Reminder for Heartland Express (HTLD)
Nasdaq · Mar 20
Nvidia's Jensen Huang Just Made a Startling Prediction. Here's What it Means …
Nasdaq · Mar 18